CK Life Sciences Intl (Holdings) Inc

Insider Reports History

Location
Central, Hong Kong
Signature
/s/ Yu Ying Choi Alan Abel, Director of CK Life Sciences Int'l., (Holdings) Inc.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CK Life Sciences Intl (Holdings) Inc:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dogwood Therapeutics, Inc. Director, Other*, 10%+ Owner Series A-1 Preferred Stock 284 $1,993 $7.01 12 Mar 2025 Indirect

Insider Reports Filed by CK Life Sciences Intl (Holdings) Inc

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DWTX Dogwood Therapeutics, Inc. 12 Mar 2025 1 +$1,993 4 Director, Other*, 10%+ Owner 17 Mar 2025, 21:07